Utility of the predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men aged 65 to 84 years is dependent on context defined by Apo E genotype and area of residence

Clinical Genetics

Volumn 56, Issue 5, 1999, Pages 367-377

  Stengård, Jari H ^a,b   Kardia, Sharon L ^b   Tervahauta, Markku ^c   Ehnholm, Christian ^a   Nissinen, Aulikki ^c,d   Sing, Charles F ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Apo E polymorphism; Elderly men; Known risk factors; Prediction of CHD mortality

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CORONARY RISK; FINLAND; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

ALOCASIA MACRORRHIZOS;

EID: 0342514606     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.1999.560505.x     Document Type: Article

References (33)

1. Goldberg RJ. Coronary heart disease: epidemiology and risk factors. In: Ockene IS, Ockene J, eds. Prevention of Coronary Heart Disease. New York: Little, Brown and Co, 1992: 3-39.
2. McGill HC Jr. Major risk factors and primary prevention, Part 1. In: Ross VFR, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia, PA: Lippincott-Raven, 1996: 25-38.
3. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988: 8: 1-21.
4. Davignon J. Apolipoprotein E polymorphism and arteriosclerosis. In: Born GVR, Schwartz CJ, eds. New Horizons in Coronary Heart Disease. London: Current Science, 1993: 5.1-5.21.
5. Sing CF, Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985: 37: 268-285.
6. Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb 1991: 11: 1330-1348.
7. Haviland MB, Lussier-Cacan S, Davignon J, Sing CF. Impact of apolipoprotein E genotype variation on means variances, and correlations of plasma lipid, lipoprotein, and apolipoprotein traits in octogenarians. Am J Med Genet 1995: 58: 315-331.
8. Reilly SL, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances. Am J Hum Genet 1991: 49: 1155-1166.
9. Reilly SL, Ferrell RE, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, MN. III. Correlations and covariances. Am J Hum Genet 1994: 55: 1001-1018.
10. Stengård JH, Pekkanen J, Ehnolm C, Nissinen A, Sing CF. Genotypes with the apolipoprotein ε4 allele are predictors of coronary heart disease in mortality in a longitudinal study of elderly Finnish men. Hum Genet 1996: 97: 677-684.
11. Reilly SL, Kottke BA, Ferrell RE, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester. MN. II. Regression relationships with concomitants. Am J Hum Genet 1992: 51: 1311-1324.
12. Pekkanen J. Coronary heart disease during a 25-year follow-up. Risk factors and their secular trends in the Finnish cohorts of the Seven Countries Study, (thesis, University of Helsinki, Finland). 1987.
13. Keys A, Aravanis C, Blackburn HW, van Buchem FSP, Buzina R, Djordjevic BS. Epidemiological studies related to coronary heart disease; characteristics of men aged 40-59 in seven countries. Acta Med Scand 1967: 460: 1-392.
14. Nissinen A, Tervahauta M, Pekkanen J, Kostiainen E, Piippo H. Levels of some biological risk indicators among elderly men in Finland. Age Ageing 1986: 15: 203-211.
15. Nissinen A, Tervahauta M, Pekkanen J, Kivinen P, Stengård J, Kaarsalo E, Kivelä S-L, Väisänen S, Salonen JT, Tuomilehto J. Prevalence and change of cardiovascular risk factors among men born 1900-1919: the Finnish cohorts of the Seven Countries Study. Age Ageing 1993: 22: 365-376.
16. Kostner GM. Enzymatic determination of cholesterol in HDL fractions prepared by polyanion precipitation. Clin Chem 1976: 22: 695.
17. Havekes LM, de Knijff P, Beisiegel U, Havinga J, Smit M, Klasen E. A rapid micromethod for apolipoprotein E phenotyping directly in serum. J Lipid Res 1987: 28: 455-463.
18. Karvonen MJ, Orma E, Punsar S, Kallio V, Arstila M, Luomanmäki K. VI. Five-year experience in Finland. Circulation 1970: XLI & XLII: 1-52 1-62.
19. Heliövaara M, Karvonen MJ, Punsar S, Rautanen Y, Haapakoski J. Serum thiocyanate concentration and cigarette smoking in relation to overall mortality and to deaths from coronary heart disease and lung cancer. J Chronic Dis 1981: 34: 305-311.
20. Everitt BS. Statistical Methods in Medical Investigations. New York, NY: Halsted Press, 1994.
21. Hosmer DW, Lemeshow S. Applied Logistic Regression. Toronto: Wiley, 1989.
22. Harris T, Cook EF, Kannel WB, Goldman L. Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. J Am Geriatr Soc 1988: 36: 1023-1028.
23. Denke MA, Winker MA. Cholesterol and coronary heart disease in older adults; No easy answers. JAMA 1995: 274: 575-577.
24. Corti M-C, Guralnik JM, Salive ME, Harris T, Field TS, Wallace RB, Berkman LF, Seeman TE, Glynn RJ, Hennekens CH, Havlik RJ. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA 1995: 274: 539-544.
25. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. New Engl J Med 1998: 338: 1-7.
26. Assmann G, Schulte H. Diabetes mellitus and hypertension in the elderly: concomitant hyperlipidemia and coronary heart disease risk. Am J Cardiol 1989: 63: 33H-37H.
27. Barrett-Connor E, Suarez L, Khaw K-T, Criqui MH, Wingard DL. Ischemic heart disease risk factors after age 50. J Chronic Dis 1984: 37: 903-908.
28. Tervahauta M, Pekkanen J, Nissinen A. Risk factors of coronary heart disease and total mortality among elderly men with and without preexisting coronary heart disease. Finnish cohorts of the Seven Countries Study. J Am Coll Cardiol 1995: 26 (7): 1623-1629.
29. Stengård JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995: 91: 265-269.
30. Falconer D, MacKay TFC. Introduction to Quantitative Genetics. Redwood City, CA: Addison-Wesley, 1996.
31. Kardia SLR, Haviland MB, Sing CF. Correlates of family history of coronary artery disease in children. J Clin Epidemiol 1998: 51: 473-486.
32. Ockene IS. The rationale for intervention. In: Ockene IS, Ockene J, eds. Prevention of Coronary Heart Disease. New York: Little, Brown and Co. 1992: 103-122.
33. Grundy SM. Lipids, nutrition, and coronary heart disease. In: Foster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippinocott-Raven, 1996.